I am a Biomedical Engineer. When I was in the last year of my master’s degree, I was working for a different medical device company that focused on orthopedics. One day I got a phone call from Prof. Moshe Phillip, the Director of the Institute for Endocrinology and Diabetes at Schneider Children’s Medical Center of Israel. He offered that I join him to help create a team that will build an artificial pancreas. I was fascinated by this challenge.
Learning about the pains of people with diabetes as well as their healthcare worker’s responsibility, drew me to want to impact those people. We were a small team, a combination of great engineers and doctors, that had to self-learn about technology, clinical studies, FDA and CE regulations as well as doing business. I am so proud that we managed to partner with Medtronic Diabetes and now our technology is part of their Medtronic 780G system.
As part of our journey, we found out that not all of the people with diabetes had access to expert care, as the great doctors in Schneider Children’s, mainly because there are not enough experts compared to the number of people with diabetes that need their help. Out of this frustration, we decided to establish DreaMed, spin out of the hospital, and build a technological bridge in the form of an AI-based platform that delivers and leverages medical knowledge for the benefit of humanity’s health.
Focusing initially on diabetes, we provide a SaaS clinical decision support system for healthcare providers that dramatically increases global patients’ accessibility to the high-quality expert standard of medical care.
How has the company evolved during the pandemic?
Interestingly, it actually pushed us forward! We had to invent our onboarding process to be purely remote. Diabetes clinics suddenly understood (a change this is here to stay) what it meant to deliver care remotely. This even elevated their need for a platform that could support them in performing this task.
On the other hand, we did experience, in some cases, issues of lack of attention of the medical team and their administrators due to COVID.
More from Interviews
- Meet Henry Wilkinson, Co-Founder at Drop-in, Ahead Of The Opening Of Drop-in Richmond
- Meet Oli Cook, CEO and Founder of ekko.
- Meet Marko Maras, CEO and Founder of Trustfull
- Meet Jeff Warren, Chief Technology Officer at Netwrix
- Evgeny Filichkin, Investment Advisor at Keytom & FinTech50 Judge, Tells Us What He’s Looking For From Entrants
- Tracy Prandi-Yuen, VP, Global Partnerships at Boku Inc. & FinTech50 Judge, Tells Us What She’s Looking For From Entrants
- Valentina Drofa, Co-Founder and CEO at Drofa Comms & FinTech50 Judge, Tells Us What She’s Looking For From Entrants
- Meet Oliver Bourne, Co-Founder Of WYSPR
What advice would you give to other aspiring entrepreneurs?
The best advice I could give is always dream big, assuming you will be successful. Then, look back and progress towards that dream step-by-step. One of the inspiring movies I saw was “The Greatest Showman.” In its theme song, ‘A Million Dreams’ it says: “They can say, they can say it all sounds crazy. They can say, they can say I’ve lost my mind. I don’t care, I don’t care, so call me crazy. We can live in a world that we design.” I really connected to these words.
What can we hope to see from DreaMed in the future?
DreaMed will become the standard of care for treating people with chronic conditions. In the next 12-18 months, you could expect to see more and more healthcare institutions choosing DreaMed technology to manage their diabetes population as well as getting the necessary funds to support our activities.
